Skip to main content
SpringerLink
Log in

Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Dyslipidemia in children with chronic kidney disease (CKD) is identified based on lipid profile parameters; however, changes in lipoprotein quality precede quantitative changes.

Methods

A cross-sectional study was done from January to October 2021; overweight, obese children, known cases of diabetes mellitus, hypothyroidism or on steroid therapy, or lipid lowering drugs were excluded. Clinical details were elicited and examinations done. Besides hemogram, kidney function tests, liver function tests, total cholesterol, low density lipoproteins (LDL), triglycerides, high density lipoproteins (HDL), and apolipoproteins A-1 and B were estimated to identify dyslipidemia. Relevant tests of significance were applied, and ROC curves were drawn for apoA-1, apoB, and apoB/apoA-1 ratios.

Results

A total of 76 (61 M:15 F) children with median (IQR) age 7 (3.25–11) years were enrolled; cause of CKD was CAKUT in 82.3% patients. Dyslipidemia (alteration of 1 or more lipid parameters) was seen in 78.9% with a prevalence of 71.7% in early and 95.7% in later stages of CKD (P = 0.02); most had elevated serum triglyceride levels. The median (IQR) values of apoB, apoA-1, and apoB/apoA-1 ratio were 78 (58–110) mg/dl, 80 (63–96.75) mg/dl, and 0.88 (0.68–1.41), respectively; apoB, apoA-1, and apoB/apoA-1 ratio had a sensitivity of 26.67%, 86.67%, and 70%, respectively, and specificity of 87.5%, 62.5%, and 62.5%, respectively, for diagnosis of dyslipidemia. The ROC for apoB, apoA-1, and apoB/apoA-1 ratio showed AUC of 0.66, 0.68, and 0.74 (P = 0.4, 0.02, < 0.01), respectively.

Conclusions

The prevalence (78.9%) of dyslipidemia was high in patients with CKD especially in those with later stages. The ratio of apoB/apoA-1 was altered early and appears to be promising for early detection.

Graphical Abstract

A higher resolution version of the Graphical abstract is available as Supplementary information

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data, though not part of a repository is available from the corresponding author.

References

  1. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Rossert J, Coresh J (2005) A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089–2100

    Article  PubMed  Google Scholar 

  2. Kaysen GA (2006) Dyslipidemia in chronic kidney disease causes and consequences. Kidney Int 70:55–58

    Article  Google Scholar 

  3. Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ (2000) Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis 35:852–862

    Article  CAS  PubMed  Google Scholar 

  4. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033

    Article  CAS  PubMed  Google Scholar 

  5. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952

    Article  PubMed  Google Scholar 

  6. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363

    Article  CAS  PubMed  Google Scholar 

  7. Saland JM, Peirce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC et al (2010) Dyslipidemia in children with chronic kidney disease: a report of chronic kidney disease in children (CKiD) study. Kidney Int 78:1154–1163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Khandelwal P, Murugan V, Hari S, Lakshmy R, Sinha A, Bagga A et al (2016) Dyslipidemia carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Pediatr Nephrol 31:1313–1320

    Article  PubMed  Google Scholar 

  9. Wanner C, Tonelli M (2014) Kidney disease: improving global outcomes lipid guideline development work group members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303–1309

  10. Khadilkar V, Yadav S, Agarwal KK (2015) Revised IAP growth charts for height, weight and body mass index for 5 to 18year old children. Indian Pediatr 52:47–55

    Article  PubMed  Google Scholar 

  11. De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660–667

    Article  PubMed  PubMed Central  Google Scholar 

  12. NCEP Expert Panel of Blood Cholesterol Levels in Children and Adolescents (1992) National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89:495–501

    Article  Google Scholar 

  13. Kuznik A, Mardekian J, Tarasenko L (2013) Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001–2010. BMC Nephrol 14:132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412–423

    Article  Google Scholar 

  15. Yaseen RI, El-Leboudy MH, El-Deeb HM (2021) The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome. Egypt Heart J 73:24

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jing F, Mao Y, Guo J, Zhang Z, Li Y, Ye Z, Ding Y, Wang J, Jin M, Chen K (2014) The value of apolipoprotein B/apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study. Lipids Health Dis 13:81

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jankowski J, Floege J, Fliser D, Böhm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143:1157–1172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Thompson A, Danesh J (2006) Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 259:481–492

    Article  CAS  PubMed  Google Scholar 

  19. Walldius G, de Faire U, Alfredsson L, Leander K, Westerholm P, Malmström H, Ivert T, Hammar N (2021) Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-experience from the Swedish AMORIS cohort: a cohort study. PLoS Med 18:e1003853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ardissino G, Daccò V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) ItalKid project (epidemiology of chronic renal failure in children: data from the ItalKid project). Pediatrics 111:382–387

    Article  Google Scholar 

  21. Mong Hiep TT, Ismaili K, Collart F, Van Damme-Lombaerts R, Godefroid N, Ghuysen MS, Van Hoeck K, Raes A, Janssen F, Robert A (2010) Clinical characteristics and outcomes of children with stage 3–5 chronic kidney disease. Pediatr Nephrol 25:935–940

    Article  PubMed  Google Scholar 

  22. Baek HS, Kim SH, Kang HG, Choi HJ, Cheong HI, Ha IS, Han KH, Cho HY, Shin JI, Park YS, Lee JH, Ahn YH, Park E, Cho MH (2020) Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for outcomes in patients with pediatric CKD). Pediatr Nephrol 35:1455–1461

    Article  PubMed  Google Scholar 

  23. National Family Health Survey (NFHS-5) 2019–2021. https://main.mohfw.gov.in/sites/default/files/NFHS-5_Phase-II_0.pdf

  24. Warady BA, Silverstein DM (2014) Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease. Pediatr Nephrol 29:1493–1505

    Article  PubMed  Google Scholar 

  25. Kwan B, Kronenberg F, Beddhu S (2007) Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 18:1246–1261

    Article  CAS  PubMed  Google Scholar 

  26. Bircan Z, Kaplan A, Soran M, Söker M, Kervancioğlu M, Sahin A, Kilinc M (1997) The effect of metabolic acidosis on serum apolipoprotein A I and apolipoprotein B levels in children with chronic renal failure. Int Urol Nephrol 29:603–607

    Article  CAS  PubMed  Google Scholar 

  27. Sniderman AD (1988) Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease. Can J Cardiol 4(Suppl A):24–30

    Google Scholar 

  28. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D et al (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoprotein A-1 and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 104:1108–1113

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No financial grant was received for the conduct of the study.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, 110002, India

    Akshay Kumar M.

  2. Division of Pediatric Nephrology, Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, 110002, India

    Mukta Mantan

  3. Department of Biochemistry GIPMER, University of Delhi, New Delhi, India

    Bhawna Mahajan

Authors
  1. Akshay Kumar M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mukta Mantan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bhawna Mahajan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mukta Mantan.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Graphical abstract (PPTX 88 KB)

Supplementary file2 (DOC 66 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

M., A.K., Mantan, M. & Mahajan, B. Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD. Pediatr Nephrol 39, 849–856 (2024). https://doi.org/10.1007/s00467-023-06144-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-023-06144-0

Keywords

Search

Navigation